Blueprint MedTech Cycle 2 Annoucement - POCTRN
The Point of Care Technology Research Network develops technologies with clinical applications using a network model that enhances complementary strengths and builds multidisciplinary partnerships.
2023 POCTRN awardees announced
Congratulations to the six Technology Research and Development Centers around the country that comprise the Point-of-Care Technology Research Network (POCTRN). Established in 2007 by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), POCTRN has facilitated a pipeline of technologies and expertise that address health conditions from heart disease to cancer to HIV/AIDS and that extends across domains from child health to global health.
Coordination among all the centers will continue to be led by CIMIT, who will reprise their role as the POCTRN Coordinating Center. Each center will use a milestone-driven approach to focus resources on the development of technologies that demonstrate the highest chance of success. Learn more about each center below.Atlanta Center for Microsystems Engineered Point-of-Care Technologies
Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases
Center for Innovation in Point-of-Care Technologies for HIV/AIDS and Emerging Infectious Diseases at Northwestern
Center for Advancing Point of Care in Heart, Lung, Blood, and Sleep Diseases
Center for Point of Care Technologies for Nutrition, Infection, and Cancer in Global Health at Cornell University
The Center for Innovation and Translation of Point of Care Technologies for Equitable Cancer Care
Center news
Funding Opportunity: Blueprint MedTech Spring Award Competition
CIMIT’s CINTA and NeuroTech Harbor, through the NIH Blueprint MedTech program, have started accepting pre-proposals from academic and industry applicants who have emerging technologies that aim to improve the prevention, diagnosis, and/or treatment of disorders involving the nervous system or consequences of such a disease or injury.
Awards up to $500K will be made available to the most promising and innovative neurotechnologies to help accelerate their development toward commercialization.
A major emphasis of this program is to create opportunities for diverse innovators, including those who have been traditionally underrepresented in the neurotech space.
Program Details:
- Awards up to $500K to help support development toward commercialization
- Mentorship from experienced medtech commercialization experts
- Support to address business, regulatory, clinical, and technical project areas
The deadline for this opportunity has passed.
POCTRN and COVID-19
In response to COVID-19 pandemic, POCTRN has helped to launch the Rapid Acceleration of Diagnostics (RADx) initiative to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19. We have also curated a number resources and additional funding opportunities on our resources page.
Explore RADx
RADx Tech
RADx Tech II
RADx Tech High-Performance Tests
RADx Tech Accessible Tests
ITAP
Webinars
Our partners
National Heart, Lung, and Blood Institute
National Institute of Allergy and Infectious Diseases
National Center for Complementary and Integrative Health
Fogarty International Center
Office of Behavioral and Social Sciences Research
Office of AIDS Research
Office of Disease Prevention